Darzalex global sales reach $4.2 billion in Q2 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Darzalex global sales reach $4.2 billion in Q2 2026

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

July 15, 2026 6:22 AM EDT

Company Announcement

Net sales of DARZALEX® in the second quarter of 2026 totaled USD 4,207 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)

COPENHAGEN, Denmark; July 15, 2026 Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX... More